{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:16:43Z","timestamp":1761175003909,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T00:00:00Z","timestamp":1485216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ijid.2017.01.024","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T19:32:11Z","timestamp":1486063931000},"page":"274-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model"],"prefix":"10.1016","volume":"56","author":[{"given":"Martin","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Cadieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei","family":"Arsenian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreemanta","family":"Parida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Dodoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alimuddin","family":"Zumla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Maeurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2017.01.024_bib0005","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2017.01.024_bib0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.ijid.2017.01.024_bib0015","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"Bmj"},{"key":"10.1016\/j.ijid.2017.01.024_bib0020","doi-asserted-by":"crossref","first-page":"e32567","DOI":"10.1371\/journal.pone.0032567","article-title":"Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan","volume":"7","author":"Favorov","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.ijid.2017.01.024_bib0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies\u2013a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"The Lancet Respiratory medicine"},{"key":"10.1016\/j.ijid.2017.01.024_bib0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14760584.2014.905746","article-title":"The BCG replacement vaccine VPM1002: from drawing board to clinical trial","volume":"13","author":"Kaufmann","year":"2014","journal-title":"Expert review of vaccines"},{"key":"10.1016\/j.ijid.2017.01.024_bib0035","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.vaccine.2016.03.069","article-title":"Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON((R))-TB Gold (+) Kenyan adults without evidence of tuberculosis","volume":"34","author":"Walsh","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2017.01.024_bib0040","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"The Lancet Infectious diseases"},{"key":"10.1016\/j.ijid.2017.01.024_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial","author":"Spertini","year":"2015","journal-title":"The Lancet Respiratory medicine"},{"key":"10.1016\/j.ijid.2017.01.024_bib0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O'Garra","year":"2013","journal-title":"Annual review of immunology"},{"key":"10.1016\/j.ijid.2017.01.024_bib0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12269","article-title":"The human immune response to tuberculosis and its treatment: a view from the blood","volume":"264","author":"Cliff","year":"2015","journal-title":"Immunological reviews"},{"key":"10.1016\/j.ijid.2017.01.024_bib0060","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/cid\/civ614","article-title":"B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis","volume":"61","author":"Rao","year":"2015","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.ijid.2017.01.024_bib0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7774\/cevr.2014.3.2.155","article-title":"Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis","volume":"3","author":"Yuk","year":"2014","journal-title":"Clinical and experimental vaccine research"},{"key":"10.1016\/j.ijid.2017.01.024_bib0070","doi-asserted-by":"crossref","first-page":"e3840","DOI":"10.1371\/journal.pone.0003840","article-title":"Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M tuberculosis","volume":"3","author":"Gaseitsiwe","year":"2008","journal-title":"PloS one"},{"key":"10.1016\/j.ijid.2017.01.024_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.colsurfb.2009.08.022","article-title":"Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations","volume":"75","author":"Anderson","year":"2010","journal-title":"Colloids and surfaces B, Biointerfaces"},{"key":"10.1016\/j.ijid.2017.01.024_bib0080","doi-asserted-by":"crossref","first-page":"e51618","DOI":"10.1371\/journal.pone.0051618","article-title":"Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A","volume":"7","author":"Lambert","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.ijid.2017.01.024_bib0085","doi-asserted-by":"crossref","first-page":"e0146372","DOI":"10.1371\/journal.pone.0146372","article-title":"The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction","volume":"11","author":"Dubois Cauwelaert","year":"2016","journal-title":"PloS one"},{"key":"10.1016\/j.ijid.2017.01.024_bib0090","doi-asserted-by":"crossref","first-page":"e13677","DOI":"10.1371\/journal.pone.0013677","article-title":"A synthetic adjuvant to enhance and expand immune responses to influenza vaccines","volume":"5","author":"Coler","year":"2010","journal-title":"PloS one"},{"issue":"7","key":"10.1016\/j.ijid.2017.01.024_bib0095","doi-asserted-by":"crossref","first-page":"e41144","DOI":"10.1371\/journal.pone.0041144","article-title":"Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140","volume":"7","author":"Arias","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2017.01.024_bib0100","doi-asserted-by":"crossref","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Science translational medicine"},{"key":"10.1016\/j.ijid.2017.01.024_bib0105","doi-asserted-by":"crossref","first-page":"42584","DOI":"10.1074\/jbc.M406134200","article-title":"Molecular dissection of the role of two methyltransferases in the biosynthesis of phenolglycolipids and phthiocerol dimycoserosate in the Mycobacterium tuberculosis complex","volume":"279","author":"Perez","year":"2004","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.ijid.2017.01.024_bib0110","doi-asserted-by":"crossref","first-page":"42574","DOI":"10.1074\/jbc.M406246200","article-title":"Characterization of three glycosyltransferases involved in the biosynthesis of the phenolic glycolipid antigens from the Mycobacterium tuberculosis complex","volume":"279","author":"Perez","year":"2004","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.ijid.2017.01.024_bib0115","doi-asserted-by":"crossref","first-page":"15177","DOI":"10.1074\/jbc.M710275200","article-title":"Deciphering the genetic bases of the structural diversity of phenolic glycolipids in strains of the Mycobacterium tuberculosis complex","volume":"283","author":"Malaga","year":"2008","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.ijid.2017.01.024_bib0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/CVI.00208-09","article-title":"Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401","volume":"17","author":"Gaseitsiwe","year":"2010","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"10.1016\/j.ijid.2017.01.024_bib0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2334-12-41","article-title":"Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus","volume":"12","author":"Ahmed","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2017.01.024_bib0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2334-13-125","article-title":"Differential cellular recognition pattern to M: tuberculosis targets defined by IFN-gamma and IL-17 production in blood from TB+patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras","volume":"13","author":"Alvarez-Corrales","year":"2013","journal-title":"BMC infectious diseases"},{"key":"10.1016\/j.ijid.2017.01.024_bib0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/infdis\/jir769","article-title":"GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults","volume":"205","author":"Behzad","year":"2012","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.ijid.2017.01.024_bib0140","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/IAI.05552-11","article-title":"Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis","volume":"80","author":"Leepiyasakulchai","year":"2012","journal-title":"Infection and immunity"},{"key":"10.1016\/j.ijid.2017.01.024_bib0145","doi-asserted-by":"crossref","first-page":"e41205","DOI":"10.1371\/journal.pone.0041205","article-title":"Mycobacterium tuberculosis infection interferes with HIV vaccination in mice","volume":"7","author":"Ignatowicz","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.ijid.2017.01.024_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1196\/annals.1358.010","article-title":"The immune response to BCG vaccination of newborns","volume":"1062","author":"Hanekom","year":"2005","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.ijid.2017.01.024_bib0155","doi-asserted-by":"crossref","first-page":"e51381","DOI":"10.1371\/journal.pone.0051381","article-title":"Long-lived memory B-cell responses following BCG vaccination","volume":"7","author":"Sebina","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.ijid.2017.01.024_bib0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.vaccine.2014.12.011","article-title":"Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis","volume":"33","author":"Schepers","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2017.01.024_bib0165","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2017.01.024_bib0170","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI38482","article-title":"Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans","volume":"119","author":"Bruns","year":"2009","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.ijid.2017.01.024_bib0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1546-0096-12-45","article-title":"Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-alpha reagents","volume":"12","author":"Yasui","year":"2014","journal-title":"Pediatric rheumatology online journal"},{"key":"10.1016\/j.ijid.2017.01.024_bib0180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/jiv055","article-title":"Interferon gamma and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis","volume":"212","author":"Orr","year":"2015","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.ijid.2017.01.024_bib0185","doi-asserted-by":"crossref","first-page":"e78966","DOI":"10.1371\/journal.pone.0078966","article-title":"The tuberculosis vaccine candidate Bacillus Calmette-Guerin DeltaureC:hly coexpressing human interleukin-7 or \u221218 enhances antigen-specific T cell responses in mice","volume":"8","author":"Rao","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.ijid.2017.01.024_bib0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imr.12276","article-title":"B cells and antibodies in the defense against Mycobacterium tuberculosis infection","volume":"264","author":"Achkar","year":"2015","journal-title":"Immunological reviews"},{"key":"10.1016\/j.ijid.2017.01.024_bib0195","first-page":"13","article-title":"Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis","volume":"32","author":"Axelsson-Robertson","year":"2015","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"key":"10.1016\/j.ijid.2017.01.024_bib0200","first-page":"23","article-title":"Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment","volume":"32","author":"Axelsson-Robertson","year":"2015","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217300279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217300279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:38:11Z","timestamp":1761118691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971217300279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":40,"alternative-id":["S1201971217300279"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2017.01.024","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2017.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}